By Nicholas Timmins, Public Policy Editor Some 800 patients a year are being refused funding for drugs that can tackle - but not cure - rare or advanced cancers, according to a survey by the Rarer Cancers Forum, a patient group. The survey also reveals the apparently random local process that decides both whether patients will receive drug treatment for their -condition and how they can access it. You have viewed your allowance of free articles. If you wish to view more, click the...
[read full story]